Clinical Study on the Prevention of Allergic Conjunctivitis with Sanfu Tie and Traditional Chinese Medicine

Clinical Study on Prevention and Treatment of Allergic Conjunctivitis with Traditional Chinese Medicine

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064911

Enrollment

Unknown

Registered

2022-10-21

Start date

2022-03-15

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Conjunctivitis

Interventions

Group 1:Oral Chinese medicine + Acupoint Application

Group 2:Chinese medicine placebo + Acupoint Application

Group 3:Chinese medicine placebo + acupoint application placebo

Eligibility

Sex/Gender

All

Age

12 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of allergic conjunctivitis with recurrence for two years or more; 2. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have other serious eye diseases in addition to allergic conjunctivitis; 2. Have undergone ophthalmic surgery in the previous 6 months; 3. Allergic to the components of the drug; 4. The keratoscope was worn during the study; 5. Concurrent use of drugs that interfere with the evaluation of drug efficacy ; 6. Pregnant or breastfeeding women; 7. Combined with serious primary diseases of cardiovascular,cerebrovascular, liver and kidney, hematopoietic system and mental patients.

Design outcomes

Primary

Measure	Time frame
ocular symptoms;ocular signs;	—

Secondary

Measure	Time frame
Nasal symptoms;	—

Countries

China

Contacts

Public ContactSong Jiantao

Eye Hospital of China Academy of Chinese Medical Sciences

Jangts@163.com+86 18600410188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026